Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial

BACKGROUND: A wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant rapidly resulted in a steep increase in the infected population and an overloaded healthcare system. Effective medications for Omicron are currently limited. The previous observational study supports t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiangru, Zhou, Shuang, Chen, Caiyu, Li, Jinhua, Wu, Hongze, Jin, Guoqiang, Zhou, Jing, Wang, Gang, Cao, Min, Sun, Ding, Zhang, Wen, Peng, Wei, Pu, Yuting, Sun, Yuting, Fang, Bangjiang, Xu, Jianguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616513/
https://www.ncbi.nlm.nih.gov/pubmed/36334390
http://dx.doi.org/10.1016/j.phymed.2022.154514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616513/
https://www.ncbi.nlm.nih.gov/pubmed/36334390
http://dx.doi.org/10.1016/j.phymed.2022.154514

Ejemplares similares